Inhibikase Therapeutics, Inc. (IKT)
Next report date and post-earnings actuals — standardized metrics from the filed statements. No analyst estimates, no narrative, no price targets.
Pre-earnings
The next report date (from the company's filing cadence) and how the business has been running.
Next report
Nov 13, 2026
Expected from filing cadence
EPS target
$-0.11
Estimates not sourced
Revenue target
—
Estimates not sourced
Trailing EPS (avg 4Q)
$-0.11
Beat rate last 4: 75%
Latest EPS YoY
0.0%
vs 2025-08-14
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
$0
Printed quarters
EPS beat rate (4Q)
75%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 11, 2026
EPS miss
EPS actual / est
$-0.11 / $-0.11
-2.3%
Revenue actual / est
$0 / —
—
Result
Below target
EPS vs prior estimate, when one exists
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/13/2026upcoming | $-0.11 | Pending | — | — | Pending | — |
| 8/11/2026 | $-0.11 | $-0.11 | -2.3% | — | $0 | — |
| 5/13/2026upcoming | $-0.10 | Pending | — | — | Pending | — |
| 5/12/2026 | $-0.10 | $-0.10 | 0.0% | — | Pending | — |
| 3/26/2026 | $-0.12 | $-0.09 | +25.0% | — | Pending | — |
| 11/14/2025 | $-0.13 | $-0.13 | 0.0% | — | Pending | — |
| 8/14/2025 | $-0.09 | $-0.11 | -22.2% | — | Pending | — |
| 5/14/2025 | $-0.11 | $-0.15 | -36.4% | — | Pending | — |
| 3/27/2025 | $-0.10 | $0.88 | +980.0% | — | Pending | — |
| 3/26/2025 | $-0.10 | $-0.63 | -530.0% | — | Pending | — |
| 11/14/2024 | $-0.38 | $-0.65 | -71.1% | — | Pending | — |
| 8/14/2024 | $-0.58 | $-0.66 | -13.8% | — | Pending | — |
| 5/15/2024 | $-0.79 | $-0.73 | +7.6% | — | Pending | — |
| 3/27/2024 | $-0.78 | $-0.63 | +19.2% | — | $1 | — |
| 11/14/2023 | $-1.12 | $-0.86 | +23.2% | — | $79,569 | — |
| 8/14/2023 | $-0.92 | $-1.11 | -20.7% | — | $116,410 | — |
| 5/16/2023 | $-0.15 | $-0.96 | -540.0% | — | $64,521 | — |
| 3/31/2023 | $-1.14 | $-1.02 | +10.5% | — | $53,440 | — |
| 3/30/2023 | — | $-0.20 | — | — | $123,440 | — |
| 11/14/2022 | $-0.18 | $-1.08 | -500.0% | $200,000 | $7,291 | -96.4% |
Need IKT data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.